A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia

被引：0
|
作者：
Yiyun Wang
Yingying Yang
Ruimin Hong
Houli Zhao
Guoqing Wei
Wenjun Wu
Huijun Xu
Jiazhen Cui
Yanlei Zhang
Alex H. Chang
Yongxian Hu
He Huang
机构：
[1] Zhejiang University School of Medicine,Bone Marrow Transplantation Center, The First Affiliated Hospital
[2] Zhejiang University,Institute of Hematology
[3] Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy,Zhejiang Laboratory for Systems & Precision Medicine
[4] Zhejiang University Medical Center,undefined
[5] Shanghai YaKe Biotechnology Ltd,undefined
来源：
Blood Cancer Journal | / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation
    Liu, Shuangyou
    Deng, Biping
    Yin, Zhichao
    Lin, Yuehui
    An, Lihong
    Liu, Dan
    Pan, Jing
    Yu, Xinjian
    Chen, Bingzhen
    Wu, Tong
    Chang, Alex H.
    Tong, Chunrong
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (06) : 671 - 679
  • [32] Safety and Efficacy of CD22 and CD19 Chimeric Antigen Receptor T Cell Treatment Bridging to Autologous Stem Cell Transplantation As Consolidation Therapy for B-Cell Acute Lymphoblastic Leukemia
    Qiu, Yan
    Qian, Chong-Sheng
    Zhou, Hai-Xia
    Xu, Ming-Zhu
    Kang, Li-Qing
    Sun, Ai-Ning
    Wu, De-Pei
    Yu, Lei
    Xue, Shengli
    BLOOD, 2022, 140 : 10337 - 10338
  • [33] Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
    Yang, Tingting
    Dong, Yetian
    Zhang, Mingming
    Feng, Jingjing
    Fu, Shan
    Xiao, Pingnan
    Hong, Ruimin
    Xu, Huijun
    Cui, Jiazhen
    Huang, Simao
    Wei, Guoqing
    Kong, Delin
    Geng, Jia
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [34] Sequential treatment with anti-CD19 and CD22 chimeric antigen receptor T cells in children with relapsed or refractory B acute lymphoblastic leukemia
    Chanut, Mathilde
    HEMATOLOGIE, 2023, 29 (06): : 332 - 334
  • [35] CD19 chimeric antigen receptor T cell therapy for haematological malignancies
    Ghorashian, Sara
    Pule, Martin
    Amrolia, Persis
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (04) : 463 - 478
  • [36] Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study
    Pan, Jing
    Tang, Kaiting
    Luo, Yuechen
    Seery, Samuel
    Tan, Yue
    Deng, Biping
    Liu, Feng
    Xu, Xiuwen
    Ling, Zhuojun
    Song, Weiliang
    Xu, Jinlong
    Duan, Jiajia
    Wang, Zelin
    Li, Chunyu
    Wang, Kai
    Zhang, Yibing
    Yu, Xinjian
    Zheng, Qinlong
    Zhao, Liping
    Zhang, Jiecheng
    Chang, Alex H.
    Feng, Xiaoming
    LANCET ONCOLOGY, 2023, 24 (11): : 1229 - 1241
  • [37] Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
    Iqbal, Madiha
    Jagadeesh, Deepa
    Chavez, Julio
    Khurana, Arushi
    Rosenthal, Allison
    Craver, Emily
    Epperla, Narendranath
    Li, Zhuo
    Isufi, Iris
    Awan, Farrukh T.
    Dholaria, Bhagirathbhai R.
    Maakaron, Joseph E.
    Sandoval-Sus, Jose D.
    Mishra, Rahul
    Saha, Aditi
    Annunzio, Kaitlin
    Bhaskar, Shakthi T.
    Sumransub, Nuttavut
    Fijalka, Andrew
    Ivanov, Stanislav A.
    Lin, Yi
    Kharfan-Dabaja, Mohamed A.
    BONE MARROW TRANSPLANTATION, 2024, 59 (02) : 211 - 216
  • [38] Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
    Madiha Iqbal
    Deepa Jagadeesh
    Julio Chavez
    Arushi Khurana
    Allison Rosenthal
    Emily Craver
    Narendranath Epperla
    Zhuo Li
    Iris Isufi
    Farrukh T. Awan
    Bhagirathbhai R. Dholaria
    Joseph E. Maakaron
    Jose D. Sandoval-Sus
    Rahul Mishra
    Aditi Saha
    Kaitlin Annunzio
    Shakthi T. Bhaskar
    Nuttavut Sumransub
    Andrew Fijalka
    Stanislav A. Ivanov
    Yi Lin
    Mohamed A. Kharfan-Dabaja
    Bone Marrow Transplantation, 2024, 59 : 211 - 216
  • [39] CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
    Hu, Yongxian
    Zhou, Yali
    Zhang, Mingming
    Ge, Wengang
    Li, Yi
    Yang, Li
    Wei, Guoqing
    Han, Lu
    Wang, Hao
    Yu, Shuhui
    Chen, Yi
    Wang, Yanbin
    He, Xiaohong
    Zhang, Xingwang
    Gao, Ming
    Yang, Jingjing
    Li, Xiuju
    Ren, Jiangtao
    Huang, He
    CLINICAL CANCER RESEARCH, 2021, 27 (10) : 2764 - 2772
  • [40] Phase 1 Results of CNCT19: CD19 CAR Constructed of a New Anti-CD19 Chimeric Antigen Receptor in Relapsed or Refractory Acute Lymphoblastic Leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Xu, Yingxi
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    BLOOD, 2019, 134
12345